全文获取类型
收费全文 | 1727篇 |
免费 | 121篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 62篇 |
妇产科学 | 28篇 |
基础医学 | 237篇 |
口腔科学 | 25篇 |
临床医学 | 188篇 |
内科学 | 308篇 |
皮肤病学 | 34篇 |
神经病学 | 56篇 |
特种医学 | 99篇 |
外科学 | 182篇 |
综合类 | 94篇 |
一般理论 | 1篇 |
预防医学 | 150篇 |
眼科学 | 15篇 |
药学 | 138篇 |
1篇 | |
中国医学 | 19篇 |
肿瘤学 | 196篇 |
出版年
2021年 | 16篇 |
2020年 | 16篇 |
2019年 | 16篇 |
2018年 | 21篇 |
2015年 | 41篇 |
2014年 | 46篇 |
2013年 | 50篇 |
2012年 | 52篇 |
2011年 | 57篇 |
2010年 | 57篇 |
2009年 | 48篇 |
2008年 | 46篇 |
2007年 | 56篇 |
2006年 | 33篇 |
2005年 | 43篇 |
2004年 | 40篇 |
2003年 | 41篇 |
2002年 | 28篇 |
2001年 | 33篇 |
2000年 | 39篇 |
1999年 | 35篇 |
1998年 | 38篇 |
1997年 | 28篇 |
1996年 | 36篇 |
1995年 | 34篇 |
1994年 | 33篇 |
1993年 | 30篇 |
1992年 | 25篇 |
1991年 | 32篇 |
1990年 | 30篇 |
1989年 | 50篇 |
1988年 | 61篇 |
1987年 | 55篇 |
1986年 | 37篇 |
1985年 | 42篇 |
1984年 | 38篇 |
1983年 | 36篇 |
1982年 | 26篇 |
1980年 | 17篇 |
1979年 | 26篇 |
1978年 | 31篇 |
1977年 | 24篇 |
1976年 | 15篇 |
1974年 | 25篇 |
1973年 | 32篇 |
1972年 | 26篇 |
1970年 | 23篇 |
1969年 | 15篇 |
1967年 | 16篇 |
1966年 | 19篇 |
排序方式: 共有1852条查询结果,搜索用时 15 毫秒
1.
2.
3.
AMPK在妊娠期糖尿病发病机制中的作用 总被引:1,自引:0,他引:1
腺苷酸活化蛋白激酶是一种重要的蛋白激酶,主要作用是协调代谢和能量平衡.腺苷酸活化蛋白激酶被激活后,在增加骨骼肌对葡萄糖摄取、增强胰岛素敏感性、增加脂肪酸氧化以及调节基因转录等方面发挥重要作用.已经证实脂联素有调节糖脂代谢的作用,但其作用机制尚不十分清楚,很可能是通过腺苷酸活化蛋白激酶介导,对脂联素信号转导通路的研究将成为进一步理解脂联素作用的关键所在.而脂联素又是妊娠期糖尿病的预测因子,所以腺苷酸活化蛋白激酶逐渐成为对妊娠期糖尿病研究中的焦点. 相似文献
4.
5.
6.
John Lister 《Sociology of health & illness》2006,28(7):992-995
7.
臂丛神经根性损伤膈神经移位术对青壮年患者早期呼吸功能的影响 总被引:1,自引:1,他引:0
目的研究臂丛神经损伤膈神经移位术对青壮年患者早期呼吸功能的影响.方法对16例接受膈神经移位治疗的患者,在术前、术后(10 d)进行肺功能指标的比较,同时定期进行门诊随访,观察呼吸系统自觉症状程度.结果13例术后出现了不同程度的供氧不足症状,16例全部出现一侧膈肌抬高,术后第10天肺活量(VC)、肺活量预计值百分数(VC%)分别比术前减少37.98%和26.88%,两者差异有统计学意义(tvc=11.532、tvc%=0,P<0.01).其它项目如残气量(RV)较术前轻度下降,肺总量(TLC)下降值达到术前肺总量的36.49%,残气量/肺总量比值(RV/TLC%)较术前上升了4.75%,上述各指标的差值均有统计学意义.1 s用力呼气量/用力肺活量比值(FEV1/FVC)和术前比基本无改变,但其差值有统计学意义.膈神经移位右侧(10例)与左侧(6例)术前、术后肺活量比较差异有统计学意义.术后随访8个月~2年,所有患者均无明显呼吸困难和胸闷等症状.结论膈神经移位术后对青壮年患者肺容量有较大的丧失,肺通气功能减弱和小气道阻力增加,但其丧失程度在机体自身代偿耐受范围内,不会导致急剧发生的严重呼吸功能障碍.建议对右侧臂丛神经根性损伤的患者,术前进行严格的肺、心功能检查,避免发生较为严重的并发症. 相似文献
8.
T. Hickish P. Serafinowski D. Cunningham A. Oza E. Dorland I. Judson B. C. Millar T. A. Lister A. Roldan 《British journal of cancer》1993,67(1):139-143
2''-Chlorodeoxyadenosine (2CDA) is a purine analogue selectively active against both resting and dividing lymphoid cells. Twenty-one patients with a variety of previously treated lymphoid malignancies received a total of 41 courses of 2CDA (0.1-0.15 mg/kg/day over 7 days continuous intravenous infusion) on compassionate grounds. The profile of the patient population was as follows: low grade non-Hodgkin''s lymphoma (NHL) = 8, intermediate grade NHL = 2, transformed (intermediate grade NHL) = 6, Hodgkin''s disease = 1, lymphoplasmacytoid NHL = 3 and lymphoblastic NHL = 1. The overall response rate was 53%, with three patients attaining complete remission (CR) and eight partial remission (PR). Three of 16 patients with primary resistant or resistant recurrent disease entered either CR (1) or PR (2). Ten patients had no response or progressive disease. The latter group was comprised of patients who had extensively pre-treated lymphoplasmacytoid tumours and/or poor performance status (WHO grades 2-4). The median duration of response is 6 months (range 1 to 12 months). Treatment was well tolerated and the chief toxicities were leucopenia and thrombocytopenia which were most pronounced when there was bone marrow involvement. As a result of dose limiting myelotoxicity, a dose escalation to 0.15 mg/kg/day was possible on just three occasions. These data confirm other reports of the activity of 2CDA in low grade NHL and indicate it may have activity in Hodgkin''s disease. There was no demonstrable activity in poor performance status patients or those with extensively pre-treated lymphoplasmacytoid tumours. 相似文献
9.
T S Ganesan H S Dhaliwal M S Dorreen A G Stansfeld J A Habeshaw T A Lister 《British journal of cancer》1987,55(4):437-442
Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed. Clinical features at presentation included rash, fever, lymphadenopathy and hepatosplenomegaly in 75% of patients. Polyclonal hypergammaglobulinaemia was seen in 19/20 patients; 5 had normal immunoglobulin levels. Combination chemotherapy with MVPP was the optimal treatment with 6/7 patients achieving complete remission. Duration of remission ranged from 9 months to 4 years and was significantly longer in patients achieving complete as opposed to partial remission. In 6 patients phenotype studies were performed on single cell suspensions and immunoperoxidase studies on frozen sections of 7 lymph nodes. There was a reversal of the normal T suppressor/helper cell ratio with a predominance of T suppressor cells. Loss of normal B follicles was observed histologically in all except one lymph node. Germline configuration of the beta B-chain of the T cell receptor was observed in lymph nodes of 4 patients with AILD, and a rearranged T cell receptor was observed in 1 patient in whom a second lymph node biopsy had shown alteration of the histological picture to that of T-zone lymphoma. Frozen sera of 15 patients were screened for antibodies to HTLV I and III and were found to be negative. 相似文献
10.